1. Introduction {#s0005}
===============

In patients with multiple sclerosis (MS), spinal cord (SC) damage is often thought to be responsible for a majority of clinically noted deficits ([@bb0080], [@bb0100]). The SC is less than one-tenth the size of the brain; thus, even small lesions can affect significant portions of the SC and in some cases even a small lesion in a white matter (WM) column can impair all function derived from that column. Radiologically, several studies have shown that SC pathology may provide a more direct indicator of disease progression and clinical disability than the brain can provide alone ([@bb0140], [@bb0165]).

Conventional T~1~ and T~2~ magnetic resonance imaging (MRI) methods are sensitive to inflammatory and water content change in SC MS disease ([@bb0045]) but not specific ([@bb0010]) to axonal damage or demyelination. As a result, T~1~-weighted (T~1~-w) and T~2~-w MRI contrasts remain poor indicators of the static, severity of the disease and/or disease progression. Alternatively, magnetization transfer (MT) imaging has been shown to be sensitive to changes in myelin content, even in areas free from macroscopic lesions ([@bb0110], [@bb0115], [@bb0180]).

Free water protons observed with conventional MRI methods (T~1~-w and T~2~-w imaging) are in exchange with protons associated with semi-immobile macromolecules in tissue ([@bb0215]) and thus MT is the biophysical phenomenon whereby an off-resonance (with respect to water) saturation is transferred to the free water from the semi-solid-like protons through dipole-dipole or direct chemical exchange. The magnitude of the MT effect has traditionally been quantified by the magnetization transfer ratio (MTR) and has been used in several studies to show that MT is correlated with myelin content ([@bb0035], [@bb0120], [@bb0180]). However, the MTR is only semi-quantitative and is significantly dependent on the MR acquisition parameters, as well as B~1~ and B~0~ inhomogeneities ([@bb0015]) and other non-MT-specific NMR parameters ([@bb0070], [@bb0200]).

Some of the limitations of the MTR have been rectified by modeling (often via a two-pool model) the MT signal ([@bb0185], [@bb0190]) as a function of offset-frequency of saturation and quantitatively deriving indices such as the macromolecular to free pool size ratio (PSR) and is termed quantitative MT (qMT). qMT typically utilizes several images at multiple RF irradiation powers and/or offsets, from which a so-called MT Z-spectrum can be generated for each voxel ([@bb0075]). In general, the measured Z-spectrum and associated fit (e.g. with a two-pool model -- free \[f\] and macromolecular \[m\]) generate several indices, including the PSR ([@bb0030], [@bb0060]), the MT exchange rate from the macromolecular to pool to the free pool (k~mf~), and the transverse and longitudinal relaxation rates for each pool ([@bb0200]). There is increased Interest in estimating the PSR and several studies ([@bb0150], [@bb0160], [@bb0170], [@bb0175], [@bb0180], [@bb0210]) have shown a strong correlation between the PSR and white matter myelin density. Indeed, several studies of MS have incorporated qMT in the brain of MS patients showing association between the PSR and MR measures of myelin ([@bb0025], [@bb0130], [@bb0205]).

In principle, however, qMT studies have been limited by long acquisition times due to the need to collect multiple MT-weighted images, the demand for high signal to noise ratio (SNR), and thus, are difficult to implement clinically. Recently, fast whole-brain mapping of the PSR using only a single MT-weighted image (and a reference image) ([@bb0225]) was developed and our group subsequently applied this method in the SC ([@bb0195]) and the thigh ([@bb0135]) in healthy volunteers. This fast qMT estimation procedure (single-point qMT) is accomplished by utilizing expected or measured constraints on the individual indices that comprise the two-pool model (e.g. the exchange rate, macromolecular T~2~, and the combined value T~2~R~1~ of the water pool -- see [@bb0225] for a full derivation of this model), providing an opportunity to sample fewer points along the MT z-spectrum and utilize the scan time savings for improved resolution or more rapid acquisitions. However, to date, the single point qMT has only been applied in one patient study in the brain of MS patients ([@bb0235]) utilizing constraints derived from healthy volunteers alone.

We seek to further this work by assessing whether a set of healthy-cohort-derived constraints placed on the two-pool qMT model sufficiently captures the variation within patients with multiple sclerosis as assessed in the cervical spinal cord of patients with MS, or whether it is necessary to derive individual patient-centered constraints to accurately estimate the PSR and it\'s sensitivity to MS pathology.

2. Materials and methods {#s0010}
========================

2.1. Data acquisition {#s0015}
---------------------

The local Institutional Review Board approved this study, and signed informed consent was obtained prior to examination. Data were obtained from two cohorts: 1) thirteen healthy volunteers (8 males, age range 24--33 years, mean ± standard deviation \[SD\] age 25 ± 2.5 years) and 2) eight relapsing-remitting MS (RRMS) patients (4 males, age range 30--49 years, mean ± SD age 40.5 ± 5.37 years, median EDSS score = 0, range 0--3.5) along with a primary progressive MS (PPMS) patient (male, 60 years old, EDSS score 5). Some healthy volunteers overlapped with an existing qMT study ([@bb0195]). [Table 2](#t0010){ref-type="table"} provides relevant clinical and demographic characteristics of the patients.

All MRI data were acquired on a 3.0 tesla Philips Achieva scanner (Philips Healthcare, Best, The Netherlands, software versions R3.2.2.0 and R5.1.7.1). A quadrature body coil was used for excitation, and a 16-channel neurovascular coil was used for signal reception. The field-of-view (FOV) was centered between the C3 and C4 vertebral bodies and spanned, at minimum, the C2 to C5 vertebral levels in all subjects. Second-order shimming was used to minimize image artifacts arising from susceptibility differences between bone and tissue.

The same MT protocol from [@bb0195] was used here: two MT pulse sequences were performed: 1) a low spatial resolution acquisition (1 × 1 mm^2^) at 8 offsets (∆ ω) and 2 powers (α~RF~) with a "full-fit" analysis ([@bb0220], [@bb0230]) and 2) a high-resolution acquisition (0.65 × 0.65 mm^2^) at 1 offset and power to be used with a "single-point" analysis ([@bb0225]). For the full-fit qMT experiment, MT-weighted images were acquired using a 3D MT-prepared spoiled gradient echo sequence ([@bb0190]) with a GRE readout and SENSE acceleration factor = 2 over 12 slices. Other parameters were: FOV = 150 × 150 mm^2^, and 2 signal averages. MT weighting was achieved using a 20-ms, single-lobed sinc pulse with Gaussian apodization ([@bb0195]). High-resolution, single-point MT-data were acquired using the same parameters, except a nominal in-plane resolution of 0.65 × 0.65 mm^2^ was applied with six signal averages. To correct for B~1~ and B~0~ inhomogeneities across the spinal cord, B~1~ and B~0~ maps were acquired using fast 3D techniques; T~1~ mapping was performed using a multiple flip angle (MFA) acquisition. A high-resolution multi-echo gradient echo (mFFE) scan was also performed and all echoes were averaged to generate a high grey/white matter contrast target image for registration ([@bb0065]). A detailed list of the sequence parameters is included in [Table 1](#t0005){ref-type="table"}.Table 1Scan parameters and MT prepulse parameters for the high-resolution anatomical (mFFE), low- and high-resolution MT, B~1~, B~0~, and T~1~ scans.Table 1ScanResolution (mm^3^)Scan parametersMT prepulse parametersScan time (m:ss)∆ ω (kHz)PowersmFFE0.65 × 0.65 × 5TR/TE~1~/∆TE/α:\
700/7.2/8.8 ms/28°----5:30Low-Res MT1 × 1 × 5TR/TE/α:\
50/2.3 ms/6°1, 1.5, 2, 2.5, 8, 16, 32, 100360°, 820°12:15High-Res MT0.65 × 0.65 × 5TR/TE/α:\
50/2.3 ms/6°2.5, 100820°7:00B12 × 2 × 5TR~1~/TR~2~/TE/α:\
30/130/2.8 ms/60°----1:12B02 × 2 × 5TR/TE~1~/TE~2~/α:\
50/4.6/6.9 ms/60°----0:45T11.5 × 1.5 × 5TR/TE: 20/4.6 ms\
α: 5, 15, 20, 25, 30°----1:30Total time:28:12Table 2Relevant clinical and demographic characteristics for the nine patients with MS enrolled in this study. The vast majority of the patients had virtually no disability or minimal impairment, yet, 8/9 patients presented with at least 1 spinal cord lesion spanning the volume of interest of our study. The mean lesion volume over all patients with at least one lesion was found to be 152.38 ± 81.16 mm^3^.Table 2PatientAgeSexYears of MSEDSS scoreC-spine lesion locationsLesion volume (mm^3^)[a](#tf0005){ref-type="table-fn"}141Male80C2--C4210.46244Female30C4--C5139.83338Female110C47.21441Female43.5C2--C4219.11540Male60C2--C4238.33641Female151.0N/A0749Male120C3--C589.37830Male70C3--C5104.27960Male105.0C2--C5210.46[^1]Table 3Median estimated parameter values for the k~mf~, T~2f~R~1f~, and T~2m~ in the control and patient cohorts, and the p-value from the Kruskal-Wallis test comparing each parameter in each cohort over all slices.Table 3ControlPatientp-Valuek~mf~ (s^− 1^)8.767.540.149T~2f~R~1f~0.02550.02790.355T~2m~ (μs)10.5110.260.576Table 4Mean PSR values for white matter (WM), grey matter (GM) and WM lesion (WM-Ls) data.Table 4WMGMWM-LsControl PSR0.19 ± 0.020.16 ± 0.02N/APatient PSRControl constraintsRater 10.15 ± 0.020.13 ± 0.020.12 ± 0.03Rater 20.15 ± 0.030.13 ± 0.020.12 ± 0.03Patient constraintsRater 10.15 ± 0.020.14 ± 0.020.12 ± 0.03Rater 20.16 ± 0.030.15 ± 0.030.13 ± 0.04Table 5Statistical comparisons (represented by p-values) between the healthy white matter (WM), and patient normal appearing white matter (NAWM) and WM lesions (WM-Ls) using the Wilcoxon rank-sum test for a single rater. Comparisons in the patient data are given for the PSR estimated from both the CD data and the PD data. Bolded values are considered significant results.Table 5CD PSRPD PSRHealthy WMHealthy GMNAWMWM-LsNAWMWM-LsHealthy WM1\<** 0**.**001**\<** 0**.**001**\<** 0**.**0010**.**0110**.**003**CD PSRNAWM1**0**.**015**0.190**0**.**036**WM-Ls1**0**.**011**0.328PD PSRNAWM1**0**.**015**WM-Ls1

2.2. Image processing {#s0020}
---------------------

All data analyses were performed in MATLAB R2016a (Mathworks, Natick, MA). Prior to data fitting, all images were cropped to an area immediately around the SC and co-registered to the mFFE volume using the FLIRT package from FSL v5.0.2.1 (FMRIB, Oxford, UK) ([@bb0090], [@bb0085]). The co-registration was applied on a slice by slice basis, utilized 2D rigid body registration, and was limited to translation and rotation (± 5°) in-plane only (i.e. translation in x and y, and rotation about the z-axis). Additionally, the registration used a normalized correlation search cost, and spline interpolation. Following co-registration, qMT parameter maps were generated for each volunteer and patient using the full-fit qMT model described in [@bb0220] & [@bb0230]. This model contains six independent parameters: R~1m~, R~1f~, T~2m~, T~2f~, PSR = M~0m~/M~0f~, and k~mf~ = k~fm~/PSR (subscripts "f" and "m" represent "free water" and "macromolecular" pools, respectively). The R~1obs~ (1/T~1obs~) maps were independently reconstructed by fitting the MFA data to the SPGR signal equation in the steady-state ([@bb0040]); these maps were used during MT parameter estimation (below) to estimate the parameter R~1f~ ([@bb0220], [@bb0230]). [@bb0070] & [@bb0145] showed that the signal dependence on R~1m~ is weak; therefore, R~1m~ was set equal to the R~1f~ ([@bb0225]). The remaining parameters were estimated for each voxel by fitting the full-fit qMT data to the above-described, two-pool MT model ([@bb0220], [@bb0230]). For all fitting, the nominal offset frequency and RF amplitudes were corrected in each voxel using B~0~ and B~1~ maps, respectively.

It has been shown that k~mf~, T~2m~, and the product T~2f~R~1f~ can all be fixed during the fitting process because they all exhibit relatively constant values across tissues ([@bb0195], [@bb0225]). This results in a model with one free parameter, PSR, which can be estimated from qMT data at a single offset/power (plus a reference scan). To estimate reasonable fixed parameters values for the single-point qMT analysis, histograms of k~mf~, T~2m~, and T~2f~R~1f~ were created (see [Section 2.3](#s0025){ref-type="sec"} below), and the median value of each parameter was chosen to enter into the single-point qMT analysis; the high-resolution MT-weighted images were then analyzed to estimate high-resolution PSR maps.

2.3. Single point constraints: controls vs patients {#s0025}
---------------------------------------------------

To determine whether the healthy control-derived (CD) constraints (assumptions) were similar to those from the MS patient-derived (PD) constraints, mean parameter values for T~2f~R~1f~, k~mf~, and T~2m~ were calculated over each slice for each subject, and Kruskal-Wallis (nonparametric ANOVA) test was performed to evaluate if differences exist between cohorts for all estimated parameters. Next, to estimate reasonable fixed parameter values to enter the single-point qMT analysis, histograms of T~2f~R~1f~, k~mf~, and T~2m~ that were derived from the full-fit analysis were created over the SC for all slices and for each cohort of subjects. The skewness of each histogram was also calculated, where a positive skewness indicates right-skewed data, while a negative skewness indicates left-skewed data. Lastly, the median value of each parameter from T~2f~R~1f~, k~mf~, and T~2m~ in each cohort was determined. The calculated constraints (assumptions) from the control cohort were applied to the high-resolution control qMT data to derive the PSR maps. The calculated constraints from both cohorts (CD and PD) were used to estimate two sets of high-resolution PSR maps for the patient cohort.

2.4. Tissue segmentation {#s0030}
------------------------

WM and grey matter (GM) tissues in the control cohort were segmented from the mFFE images using the multi-atlas segmentation tool ([@bb0005]) previously developed for mFFE acquisitions. Each GM/WM regions of interest (ROI) was eroded using the *imerode* tool (using a disk *strel* object with a radius of 1) from MATLAB to avoid partial volume effects and the mean PSR values from the single-point data were calculated voxel-by-voxel for each volunteer. An example segmentation is shown in [Fig. 1](#f0005){ref-type="fig"}a.Fig. 1High-resolution anatomical images in a healthy control (a.), and an MS patient for rater \#1 (b.) and rater \#2 (c.) with ROIs drawn for NAWM (blue), NAGM (green), and WM-Ls (red). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 1

Since the multi-atlas procedure does not account for lesions, WM lesion (WM-L), normal appearing white matter (NAWM), and normal appearing grey matter (NAGM) ROIs in the patient cohort were drawn manually by two independent raters on the high-resolution mFFE image (shown in [Fig. 1](#f0005){ref-type="fig"}b and c). ROIs were placed manually using MIPAV (NIH, Bethesda, MD) for each slice of each subject. The ROIs were then eroded as for the healthy control multi-atlas method to ensure only the NAWM, NAGM, and WM-Ls were identified with minimal confounding effects from partial volume effects. The mean single-point PSR was calculated for each subject and tissue type (NAWM, NAGM, WM-L).

2.5. Statistical analysis of patient and control single point PSR {#s0035}
-----------------------------------------------------------------

Statistical comparisons were performed on the mean PSR values between i) raters for the patient cohort using the PSR estimated from the patient-derived constraints, ii) each tissue type in the patient cohort (NAWM, NAGM, and WM-Ls) using both sets of derived constraints (CD and PD), and iii) the healthy control cohort (WM and GM) and the patient cohort for each tissue type and set of constraints. A significance threshold of p \< 0.05 was chosen for all statistical comparisons. The Wilcoxon rank-sum test was used for comparisons ii) and iii), while the Bland-Altman analysis ([@bb0020]), consisting of the normalized Bland-Altman difference (D~BA~), 95% confidence interval for the difference, and the limits of agreement (1.96\*SD of the difference across scans), was used for the inter-rater comparisons in i).

3. Results {#s0040}
==========

3.1. Comparison of control and patient single point constraints {#s0045}
---------------------------------------------------------------

The histograms derived from the low-resolution, full fit qMT analysis for k~mf~, T~2f~R~1f~, and T~2m~ over the whole cervical cord are shown in [Fig. 2](#f0010){ref-type="fig"} for both the control and patient groups. None of the parameter estimates were found to be significantly different between controls and patients (p-values: k~mf~ -- 0.149, T~2f~R~1f~ -- 0.355, T~2m~ -- 0.576). All histograms are single-peaked and show similar skewness between cohorts -- the k~mf~ (skewness: CD -- 2.11, PD -- 2.04) and T~2f~R~1f~ (skewness: CD -- 2.40, PD -- 2.19) are skewed to the left with long tails at high values, while the T~2m~ presents little to no skew (skewness: CD -- 0.65, PD -- 0.50). The median values for the control and patient cohorts are: \[8.76, 7.54\] s^− 1^, \[0.0255, 0.0279\], and \[10.66, 10.51\] μs for the k~mf~, T~2f~R~1f~, and T~2m~, respectively, and are also shown in [Table 3](#t0015){ref-type="table"}.Fig. 2Parameter histograms over the whole cervical SC for the healthy controls (blue) and patients (red) derived from (a.) the exchange rate, k~mf~, (b.) the T~2f~R~1f~, and (c.) the T~2m~. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 2

3.2. High-resolution single point data {#s0050}
--------------------------------------

Anatomical images, R~1obs~ maps, and PSR maps are displayed in [Fig. 3](#f0015){ref-type="fig"} for a healthy control and a patient with MS, where the constraints derived from the patient population were used to generate the PSR values. Note that the contrast in the PSR is such that WM areas have a higher PSR value (yellow-red) than GM (green), while the CSF exhibits little to no MT effect (dark blue). The average T~1obs~ values for the healthy GM and WM are \[GM: 1.37 ± 0.08 s, WM: 1.28 ± 0.08 s\], while the average T~1obs~ values in the patient GM, NAWM, and lesions are: \[GM: 1.49 ± 0.16 s, NAWM: 1.38 ± 0.14 s, Lesions: 1.49 ± 0.19 s\]. Several differences can be appreciated when the PSR in the healthy control and patient are compared. In areas associated with a lesion on the anatomical image, we see a decrease in the PSR of the patient (0.11 ± 0.03); this is reduced compared to the NAWM (0.14 ± 0.04), and the control WM (0.18 ± 0.03) PSR.Fig. 3Anatomical data (a.), R~1obs~ (b.), and PSR (c.) data for a typical healthy control and patient with MS (using the patient-derived parameters). Notice the decreased PSR over areas where a lesion is present, and in the areas surrounding these lesions (lesions outlined in red). (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)Fig. 3

The Bland-Altman plots for the inter-rater comparison are displayed in [Fig. 4](#f0020){ref-type="fig"}. The 95% confidence intervals for all tissues overlap zero, indicating there are no significant differences between raters. Furthermore, the limits of agreement in the NAWM ([Fig. 4](#f0020){ref-type="fig"}a) and GM ([Fig. 4](#f0020){ref-type="fig"}b) are within ± 1.5%, which is within one standard deviation of the mean PSR over all patients (see [Table 4](#t0020){ref-type="table"}). The lesions had the largest 95% confidence intervals and limits of agreement, indicating that the delineation of lesion boundaries produced the largest variation between raters. However, none of the tissue types were shown to be significantly different (p-values: NAWM -- 0.480, GM -- 0.07, WM-Ls -- 0.337); therefore, all subsequent analyses use only the ROIs taken from rater 1.Fig. 4Bland-Altman plots for the inter-rater reproducibility in the (a.) normal appearing white matter (NAWM), (b.) grey matter (GM), and (c.) WM lesion (WM-Ls) in the MS patients using the PSR calculated from the patient-derived constraints. The Bland-Altman differences and p-values for the NAWM, GM, and WM-Ls are \[0.398, 0.480\], \[3.975, 0.07\], and \[5.51, 0.337\], respectively.Fig. 4

Mean single-point PSR values for the healthy controls and MS patient groups are shown in [Table 4](#t0020){ref-type="table"}. In all cases the healthy PSR (WM: 0.19 ± 0.02, GM: 0.16 ± 0.02) was found to be higher than the patient PSR (CD -- NAWM: 0.15 ± 0.02, NAGM: 0.13 ± 0.02) for each respective tissue class. The lesion data displayed similar PSR values (CD WM-Ls: 0.13 ± 0.03) to the NAGM over all patients, and was in all cases lower than the PSR of the healthy WM and patient NAWM.

The statistical comparisons between the healthy and patient cohorts from the Wilcoxon rank-sum test are displayed in [Table 5](#t0025){ref-type="table"} for WM. The WM in the healthy controls was significantly different from both CD and PD PSR for all tissue types (p-values \< 0.01 for WM-Ls, p-values \< 0.05 for NAWM). Additionally, the NAWM was found to be significantly different from lesions (p \< 0.05) in all cases. The CD NAGM PSR data was found to be significantly different from the healthy GM (p = 0.008), while the PD NAGM only approached a significant value. No significant differences were observed between the PD and CD PSR data in NAWM, NAGM, or WM-L (p \> 0.15 in all cases). This demonstrates that the small differences seen in k~mf~ did not significantly affect the single point model when it was applied to a patient cohort.

4. Discussion {#s0055}
=============

The goal of this study was to evaluate how assumed constraints derived from a full qMT analysis, and applied to a single-point qMT method, are different in pathology, such as in MS. We compared the calculated constraints for each population (healthy controls and patients with MS) and evaluated the PSR across patients (using both CD and PD assumptions) in the NAWM, NAGM, and WM-Ls, as well as between MS patients and healthy controls. We demonstrated that the error observed in the full fit analysis for MS patients does not significantly bias the PSR calculations derived from the single point methodology.

To the best of our knowledge, this is the first study to perform a full qMT analysis in the SC of patients with MS and evaluating the validity of the single-point assumptions. Therefore our results, although preliminary, show important and novel conclusions. The observed k~mf~ in patients was found to be 7.54 s^− 1^, which is lower than what has been observed in healthy controls (k~mf~ = 8.76 s^− 1^). Additionally, the T~1obs~ was found to be higher in WM-Ls, compared to NAWM and healthy WM, which is expected, and incorporated into the two-pool qMT model. Therefore, our results suggest that the observed PSR changes are driven by macromolecular content rather than inflammation ([@bb0150], [@bb0180]). Nevertheless, one shall keep in mind that these changes may also be due to increased water content present in advanced WM-Ls where a high degree of tissue loss is present relative to other tissues, which would decrease both the PSR and k~mf~, and increase the T~1~. [@bb0125] recently demonstrated that the myelin water fraction (MWF) is significantly decreased in postmortem lesions relatively to NAWM and patient GM, which may explain the observed changes in T~1~ and exchange rate in patients with MS relative to healthy controls.

A potential source of bias in the above analysis is caused by using median, whole-cord values for the single point constraints (e.g. k~mf~, T~2f~R~1f~, and T~2m~), as the heterogeneity present in the NAWM, NAGM, and WM-Ls may be removed. Therefore, ROIs were also drawn in the low-resolution data for each tissue type (NAWM, NAGM, and WM-Ls), and the mean parameter values were found for each subject and tissue type. The Wilcoxon rank-sum test was performed between each patient tissue type and the mean whole-cord control data. No significant differences were found between the tissue-specific patient data and the control data (p \> 0.15 in all cases). This is an important characterization, as it further indicates that the k~mf~, T~2f~R~1f~, and T~2m~ are not sensitive to MS-induced changes, signifying that the PSR alone is an indicator of macromolecular changes in the CNS.

The high resolution PSR data in [Table 5](#t0025){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"} demonstrated significant differences between healthy WM PSR and NAWM, NAGM, and WM-Ls PSR in patients. Furthermore, the changes due to exchange rate seen from the full fit data do not present a significant difference in PSR between the CD and PD patient data. This indicates that there may be pathological changes to the neurological tissues that cannot be visualized in the anatomical data. As MT has been shown to visualize the underlying macromolecular tissue dynamics within tissues ([@bb0150], [@bb0155], [@bb0180]), these changes may reflect underlying neurological tissue changes that occur prior to more overt radiological symptoms seen in conventional imaging methodologies.

An important aspect of the PSR is its sensitivity to macromolecular-induced changes in WM. Therefore, detecting WM changes along the spinal cord would provide substantial benefits to researchers and clinicians, as the PSR could then be used to track how lesions may be affecting NAWM caudal to the lesion site. To this end, we compared how the PSR changed along the spinal cord in the patient cohort. We used the Kruskal-Wallis test (nonparametric ANOVA) to determine if the variation along the spinal cord was greater than the variation between patients for both NAWM and NAGM. Although the NAGM did not show significant differences (p = 0.26), significant differences were observed for the NAWM (p \< 0.05). In particular, near C2/C3, the NAWM PSR was approximately 0.161 ± 0.024, while the NAWM PSR was approximately 0.127 ± 0.026 near C5/C6. We have demonstrated previously ([@bb0195]) that the PSR does not display regional variations in healthy volunteers. Therefore, the PSR may be detecting regional changes in the macromolecular content due to pathology. However, further research utilizing a larger patient population is needed in order to confirm this hypothesis.

GM demyelination has recently become a topic of interest when evaluating radiological and clinical deficits associated with MS. [@bb0055] reported evidence of GM demyelination in postmortem studies of patients with MS, and found a significantly greater proportion of demyelinated GM compared with WM. [@bb0105], [@bb0095] reported GM involvement in multiple studies; this suggests that GM may be significantly affected by MS in the SC. Here, we confirm these post mortem findings with our in vivo measurements. NAGM in patients had significantly different qMT-derived measures than that of healthy persons.

The patient group introduced in this work was on average 15 years older than the respective control group, which may have contributed to some of the differences between the WM and NAWM. Indeed, a study has shown age-related changes in the MTR ([@bb0050]), which may translate to the PSR. While this study demonstrated that there were no significant differences between the CD and PD single point qMT constraints, there may be changes in the PSR due to age, which may bias any conclusions that are drawn from the data. Therefore, future studies should seek to compare patient data to age-matched control data to ensure changes are due to pathology alone.

Although the patients in this study presented with multiple focal lesions, their clinical disability scores were fairly low. While the highest Expanded Disability Status Scale (EDSS) score in the patient cohort was 5, most of the patients had EDSS scores of 1 or 0, which biases correlations that could be performed. Addressing the impact of our qMT-derived measures on clinical disability was outside the scope of this work which was not powered towards that. Nevertheless, this is the next logical continuation of this study. Our group is already expanding the work to a larger cohort of MS patients with a more heterogeneous clinical expression of the disease to assess the clinical implications of our imaging findings.

5. Conclusions {#s0060}
==============

This study demonstrated that a set of control-derived constraints can be used to accurately map PSR data in patients with MS. Our results also demonstrate that the PSR is an important tool to quantify MS, and may provide a more stable measure of the effects of demyelination and axonal damage than can be provided through conventional imaging alone. Developing clinically-oriented metrics to quantify tissue pathologies may offer additional insights into disease diagnosis and progression.
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[^1]: Measured using the ROIs drawn in the high resolution anatomical images.
